Of interest, other measures of weight loss such as bariatric surgery84, 85, GLP-1 receptor antagonists86, GLP-1/GIP dual agonists87 and SGL 2 inhibitors88 have been reported to reduce dementia in obese people with IR and/or T2DM. This evidence concerns the gene GLP1R and type 2 diabetes mellitus.